TipRanks
Go Ultimate55% OFF

Inspiration Healthcare (LXD1) AI Stock Analysis

DE:LXD1

Inspiration Healthcare

(Frankfurt:LXD1)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cash generation reboundThe strong 2026 operating and free cash flow rebound indicates that the core business can generate funding internally when trading improves. This supports investment in products, services and working capital while reducing reliance on external financing over the next several quarters.
Negative Factors
Continued net lossesPositive operating profit has not yet translated into bottom-line profitability, leaving the company without a proven earnings base. Continued net losses can constrain reinvestment, weaken resilience, and make the recent operating recovery less durable if performance softens.

Inspiration Healthcare (LXD1) vs. iShares MSCI Germany ETF (EWG)

-40%-20%0%20%40%60%DE:LXD1-8.04%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 15.47M
Dividend Yield
―
Average Volume (3M)
22.50K
Price to Earnings (P/E)
-25.4
Beta (1Y)
-0.56
Revenue Growth
-2.08%
EPS Growth
94.88%
Country
Germany
Employees
194
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Inspiration Healthcare Business Overview & Revenue Model

Company Description

Inspiration Healthcare Group plc (IHC.L) is a global provider of advanced medical technology, catering to critical care, operating theatre, and home healthcare applications worldwide. The company offers a comprehensive range of products, with a stron...

Inspiration Healthcare Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:LXD1 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:TSTLGB:TSTL80OutperformGBP 194.70M24.2823.05%3.51%10.02%19.83%
GB:SNGB:SN72OutperformGBP 9.27B19.5212.25%2.66%2.17%27.33%
GB:CTECGB:CTEC71OutperformGBP 4.67B51.648.40%2.28%1.94%-43.71%
GB:AMSGB:AMS67NeutralGBP 611.34M166.181.44%1.66%6.05%-60.00%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:SUNGB:SUN40UnderperformGBP 3.73M-4.00-15.47%―-3.68%20.00%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%DE:LXD1GB:AMSGB:CTECGB:SUNGB:TSTLGB:SNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:LXD1 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:LXD1Inspiration Healthcare0.21-0.02-8.04%
GB:AMSAdvanced Medical Solutions282.5067.4931.39%
GB:CTECConvaTec Group plc244.4011.174.79%
GB:SUNSurgical Innovations Group Plc0.40-0.18-31.03%
GB:TSTLTristel plc405.0058.6716.94%
GB:SNSmith & Nephew (UK)1107.50-251.88-18.53%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.